medigraphic.com

2018, Number 1

<< Back Next >>

Cir Cir 2018; 86 (1)

Incidence of complications in dermatological surgery of melanoma and non-melanoma skin cancer in patients with multiple comorbidity and/or antiplatelet-anticoagulants. Five year experience in our Hospital

Arguello-Guerra L, Vargas-Chandomid E, Díaz-González JM, Méndez-Flores S, Ruelas-Villavicencio A, Domínguez-Cherit J

Language: Spanish
References: 43
Page: 20-28
PDF size: 479.93 Kb.


ABSTRACT

Introduction: Surgery is performed more frequently now at days, due to the increasing incidence of melanoma and no-melanoma skin cancer. There are different opinions among dermatologic surgeons between to continue or discontinue antithrombotic therapy prior to the procedure, which increases the risk of thromboembolic events. Prophylaxis with oral antibiotics in the postsurgical period is controversial. Objective: To report the safety of surgery without suspending antithrombotic therapy and without oral antibiotic prophylaxis in dermatology surgery of patients with multiple comorbidities and polypharmacy. Method: We designed a retrospective study. We included a total of 655 patients; 96.6% had at least one comorbidity; 27.7% used aspirin and 4.3% some type of antithrombotic therapy. The most common type of skin tumor was basal cell carcinoma with 69.8% . Results: The complication rate was 4.2%; the most was wound dehiscence (1.1%), followed by partial necrosis (0.9%), infection (0.9%), reaction to foreign body (0.6%), complete necrosis (0.3%), bleeding (0.2%) and fistulae (0.2%). Conclusions: Based on the literature and our experience, dermatologic surgery is safe without suspending antithrombotic therapy or antibiotic prophylaxis in patients with multiple comorbidity.


REFERENCES

  1. Universidad Nacional Autónoma de México. México: Boletín UNAMDGCS- 362; c2016. (Actualizado el 26 de mayo de 2016; consultado el 11 de septiembre de 2016.) Disponible en: http://www.dgcs.unam.mx/ boletin/bdboletin/2016_362 html

  2. American Cancer Society. Cancer Facts & Figures 2016. Atlanta: American Cancer Society; 2016.

  3. Roenigk RK. Dermatologists perform more skin surgery than any other specialist: implications for health care policy, graduate and continuing medical education. Dermatol Surg. 2008;34:293-300.

  4. Alcalay J, Alkalay R. Controversies in perioperative management of blood thinnersin dermatologic surgery: continue or discontinue? Dermatol Surg. 2004;30:1091-4; discussion 1094.

  5. Kovich O, Otley CC. Perioperative management of anticoagulants and platelet inhibitors for cutaneous surgery: a survey of current practices. Dermatol Surg. 2002;28 513-7.

  6. Otley CC. Continuation of medically necessary aspirin and warfarin during cutaneous surgery. Mayo Clin Proc. 2003;78:1392-6.

  7. Callahan S, Goldsberry A, Kim H, Yoo S. The management of antithrombotic medication in skin surgery. Dermatol Surg. 2012;38:1417-26.

  8. Council ML, Alam M, Gloster HM Jr, Bordeaux JS, Carroll BT, Leitenberger JJ, et al. Identifying and defining complications of dermatologic surgery to betracked in the American College of Mohs Surgery (ACMS) Registry. J Am Acad Dermatol. 2016;74:739-45.

  9. Shurman DL, Benedetto AV. Antimicrobials in dermatologic surgery: facts and controversies. Clin Dermatol. 2010;28:505-10.

  10. Berríos-Torres SI. Evidence-based update to the U.S. Centers for Disease Control and Prevention and Healthcare Infection Control Practices Advisory Committee guideline for the prevention of surgical site infection: developmental process. Surg Infect (Larchmt). 2016;17:256-61.

  11. Bichakjian CK, Olencki T, Aasi SZ, Alam M, Andersen JS, Berg D, et al. Basal cell skin cancer, version 1 2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016;14 574-97.

  12. Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE 3rd, et al. Melanoma, version 2 2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016;14:450-73.

  13. Bichakjian CK, Olencki T, Aasi SZ, Alam M, Andersen JS, Berg D, et al. Squamous Cell Skin Cancer, version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016;14:574-97.

  14. Shipkov H, Irthum C, Seguin P, Mojallal A, Braye F. Evaluation of the risk of post-operative bleeding complications in skin cancer surgery without interruption of anticoagulant/antithrombotic medication: a prospective cohort study. J Plast Surg Hand Surg. 2015;49:242-6.

  15. Jarjis RD, Jørgensen L, Finnerup K, Birk-Sørensen L. Complications in skin grafts when continuing antithrombotic therapyprior to cutaneous surgery requiring skin grafting: a systematic review. J Plast Surg Hand Surg. 2015;49:129-34.

  16. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc. 2008;139(Suppl):3S-24S. Erratum in: J Am Dent Assoc. 2008;139:253.

  17. Harrington RA, Becker RC, Ezekowitz M, Meade TW, O’Connor CM, Vorchheimer DA, et al. Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl) 513-48S.

  18. Sabatine MS, Cannon CP, Gibson CM, López-Sendón JL,- Montalescot G, Theroux P, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352:1179-89.

  19. Otley CC, Fewkes JL, Frank W, Olbricht SM. Complications of cutaneous surgery in patients who are taking warfarin, aspirin, or nonsteroidal anti- inflammatory drugs. Arch Dermatol. 1996;132:161-6.

  20. Messingham MJ, Arpey CJ. Update on the use of antibiotics in cutaneous surgery. Dermatol Surg. 2005;31:1068-78.

  21. Maragh SL, Brown MD. Prospective evaluation of surgical site infection rate among patients with Mohs micrographic surgery without the use of prophylactic antibiotics. J Am Acad Dermatol. 2008;59:275-8.

  22. Wright TI, Baddour LM, Berbari EF, Roenigk RK, Phillips PK, Jacobs MA, et al. Antibiotic prophylaxis in dermatologic surgery: advisory statement 2008. J Am Acad Dermatol. 2008;59:464-73.

  23. Dixon AJ, Dixon MP, Dixon JB, Del Mar CB. Prospective study of skin surgery in smokers vs. nonsmokers. Br J Dermatol. 2009;160:365-7.

  24. Honaker JS, Bordeaux JS, Tuttle MS. Retrospective review of risk factors predictive of complications in patients after below the knee mohs micrographic surgery. Dermatol Surg. 2016;42 568-70.

  25. Wahie S, Lawrence CM. Wound complications following diagnostic skin biopsies in dermatology inpatients. Arch Dermatol. 2007;143:1267-71.

  26. Levender MM, Davis SA, Kwatra SG, Williford PM, Feldman SR. Use of topical antibiotics as prophylaxis in clean dermatologic procedures. J Am Acad Dermatol. 2012;66:445-51.

  27. Khadim MF, Bell PR, Rashid A, Lewis HG. A postal survey of UK practice on discontinuation of anticoagulant/antithrombotics therapy before minor cutaneous surgery of the head and neck. J Plast Reconstr Aesthet Surg. 2011;64:e213-5.

  28. Shimizu I, Jellinek NJ, Dufresne RG, Li T, Devarajan K, Perlis C. Multiple antithrombotic agents increase the risk of postoperative hemorrhage in dermatologic surgery. J Am Acad Dermatol. 2008;58:810-6.

  29. Bordeaux JS, Martires KJ, Goldberg D, Pattee SF, Fu P, Maloney ME. Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications. J Am Acad Dermatol. 2011;65:576-83.

  30. Bartlett GR. Does aspirin affect the outcome of minor cutaneous surgery? Br J Plast Surg. 1999;52:214-6.

  31. Kargi E, Babuccu O, Hosnuter M, Babuccu B, Altinyazar C. Complications of minor cutaneous surgery in patients under anticoagulant treatment. Aesthetic Plast Surg. 2002;26:483-5.

  32. Syed S, Adams BB, Liao W, Pipitone M, Gloster H. A prospective assessment of bleeding and international normalized ratio in warfarin-anticoagulated patients having cutaneous surgery. J Am Acad Dermatol. 2004;51:955-7.

  33. Shalom A, Wong L. Outcome of aspirin use during excision of cutaneous lesions. Ann Plast Surg. 2003;50:296-8.

  34. Billingsley EM, Maloney ME. Intraoperative and postoperative bleeding problems in patients taking warfarin, aspirin, and nonsteroidal antiinflammatory agents. A prospective study. Dermatol Surg. 1997;23:381-3; discussion 384-5.

  35. Schanbacher CF, Bennett RG. Postoperative stroke after stopping warfarin for cutaneous surgery. Dermatol Surg. 2000;26:785-9.

  36. Kovich O, Otley CC. Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation. J Am Acad Dermatol. 2003;48:233-7.

  37. Alcalay J. Cutaneous surgery in patients receiving warfarin therapy. Dermatol Surg. 2001;27:756-8.

  38. Goldminz D, Bennett RG. Cigarette smoking and flap and full-thickness graft necrosis. Arch Dermatol. 1991;127:1012-5.

  39. Gill JF, Yu SS, Neuhaus IM. Tobacco smoking and dermatologic surgery. J Am Acad Dermatol. 2013;68:167-72.

  40. Chan LK, Withey S, Butler PE. Smoking and wound healing problems in reduction mammaplasty: is the introduction of urine nicotine testing justified? Ann Plast Surg. 2006;56:111-5.

  41. Kimyai-Asadi A, Goldberg LH, Peterson SR, Silapint S, Jih MH. The incidence of major complications from Mohs micrographic surgery performed in office-based and hospitalbased settings. J Am Acad Dermatol. 2005;53 628-34.

  42. Hansen TJ, Lolis M, Goldberg DJ, MacFarlane DF. Patient safety in dermatologic surgery: part I. Safety related to surgical procedures. J Am Acad Dermatol. 2015;73:1-12; quiz 13-4.

  43. Otley CC. Perioperative evaluation and management in dermatologic surgery. J Am Acad Dermatol. 2006;54:119-27.




2020     |     www.medigraphic.com